Exact Mass: 347.09969920000003

Exact Mass Matches: 347.09969920000003

Found 461 metabolites which its exact mass value is equals to given mass value 347.09969920000003, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Hydroxysanguinarine

24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-one

C20H13NO5 (347.0794)


Hydroxysanguinarine is a benzophenanthridine alkaloid. Hydroxysanguinarine is a natural product found in Fumaria indica, Fumaria parviflora, and other organisms with data available.

   

Adenosine monophosphate

{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7P (347.0631)


Adenosine monophosphate, also known as adenylic acid or amp, is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenosine monophosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Adenosine monophosphate can be found in a number of food items such as kiwi, taro, alaska wild rhubarb, and skunk currant, which makes adenosine monophosphate a potential biomarker for the consumption of these food products. Adenosine monophosphate can be found primarily in most biofluids, including blood, feces, cerebrospinal fluid (CSF), and urine, as well as throughout all human tissues. Adenosine monophosphate exists in all living species, ranging from bacteria to humans. In humans, adenosine monophosphate is involved in several metabolic pathways, some of which include josamycin action pathway, methacycline action pathway, nevirapine action pathway, and aspartate metabolism. Adenosine monophosphate is also involved in several metabolic disorders, some of which include hyperornithinemia-hyperammonemia-homocitrullinuria [hhh-syndrome], molybdenum cofactor deficiency, xanthinuria type I, and mitochondrial DNA depletion syndrome. Adenosine monophosphate is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalanc. Adenosine monophosphate, also known as 5-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a Bitter Blocker additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem sweeter. This potentially makes lower calorie food products more palatable. [Spectral] AMP (exact mass = 347.06308) and Guanine (exact mass = 151.04941) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) and Glutathione disulfide (exact mass = 612.15196) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] AMP (exact mass = 347.06308) and Glutathione disulfide (exact mass = 612.15196) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] AMP (exact mass = 347.06308) and Adenine (exact mass = 135.0545) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. Adenosine monophosphate. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=67583-85-1 (retrieved 2024-07-01) (CAS RN: 61-19-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.

   

2'-Deoxyguanosine 5'-monophosphate

{[(2R,3S,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7P (347.0631)


2-Deoxyguanosine 5-monophosphate, also known as deoxyguanylic acid or 2-deoxy-GMP, belongs to the class of organic compounds known as purine 2-deoxyribonucleoside monophosphates. These are purine nucleotides with monophosphate group linked to the ribose moiety lacking a hydroxyl group at position 2. 2-Deoxyguanosine 5-monophosphate is a purine 2-deoxyribonucleoside 5-monophosphate having guanine as the nucleobase. It exists in all living species, ranging from bacteria to humans. Within humans, 2-deoxyguanosine 5-monophosphate participates in a number of enzymatic reactions. In particular, 2-deoxyguanosine 5-monophosphate can be converted into dGDP which is mediated by the enzyme guanylate kinase. In addition, 2-deoxyguanosine 5-monophosphate can be converted into deoxyguanosine through its interaction with the enzyme cytosolic purine 5-nucleotidase. In humans, 2-deoxyguanosine 5-monophosphate is involved in the metabolic disorder called the gout or kelley-seegmiller syndrome pathway. 2-Deoxyguanosine 5-monophosphate is a derivative of the common nucleic acid GTP, or guanosine triphosphate, in which the -OH (hydroxyl) group on the 2 carbon on the nucleotides pentose has been removed (hence the deoxy- part of the name). Additionally, the diphosphate of the name indicates that two of the phosphoryl groups of GTP have been removed, most likely by hydrolysis . [HMDB] Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Cephalexin

(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O4S (347.094)


Cephalexin is only found in individuals that have used or taken this drug. It is a semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of cephaloridine or cephalothin, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. [PubChem]Cephalexin, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cephalexin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; INTERNAL_ID 1046

   

3'-AMP

{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C10H14N5O7P (347.0631)


Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2-, 3-, or 5-position. 3-AMP has been identified in the human placenta (PMID: 32033212). Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2-, 3-, or 5-position. [HMDB] Acquisition and generation of the data is financially supported in part by CREST/JST. CONFIDENCE standard compound; ML_ID 11

   

Adenosine 2'-phosphate

{[(3R,4R,5R)-2-(6-amino-9H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C10H14N5O7P (347.0631)


Adenosine 2-phosphate is converted enzymatically from adenosine 2,3-cyclic phosphate via the enzyme 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). In the brain, this enzyme acts on 2,3-cyclic AMP more rapidly than on the UMP or CMP derivatives. In the liver, this enzyme acts on 2,3-cyclic CMP more rapidly than on the purine derivatives; it also hydrolyses the corresponding 3,5-cyclic phosphates, more slowly. This latter enzyme has been called cyclic-CMP phosphodiesterase. (KEGG). This enzyme belongs to the family of hydrolases, specifically those acting on phosphoric diester bonds. The systematic name of this enzyme class is nucleoside-2,3-cyclic-phosphate 2-nucleotidohydrolase. (Wikipedia). Adenosine 2-phosphate is converted enzymatically from adenosine 2,3-cyclic phosphate via the enzyme 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). In the brain, this enzyme acts on 2,3-cyclic AMP more rapidly than on the UMP or CMP derivatives. In the liver, this enzyme acts on 2,3-cyclic CMP more rapidly than on the purine derivatives; it also hydrolyses the corresponding 3,5-cyclic phosphates, more slowly. This latter enzyme has been called cyclic-CMP phosphodiesterase. (KEGG) Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2].

   

EVOXINE

2,3-Butanediol, 1-((4,8-dimethoxyfuro(2,3-b)quinolin-7-yl)oxy)-3-methyl-, (+)-

C18H21NO6 (347.1369)


   

7-alpha-D-Ribosyladenine 5-phosphate

7-(5-phospho-alpha-D-ribosyl)adenine

C10H14N5O7P (347.0631)


   

Cavinine

1,2-beta-Epoxyambelline

C18H21NO6 (347.1369)


   

S-23121

Flumipropyn; S-23121

C18H15ClFNO3 (347.0724)


   

Pyriminobac

UNII-324VPI7F2Z

C16H17N3O6 (347.1117)


   
   

2-hydroxy-dAMP

{[(2R,3S,5R)-5-(6-amino-2-hydroxy-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7P (347.0631)


2-hydroxy-damp is a substrate for: 7,8-dihydro-8-oxoguanine triphosphatase.

   

Dide-O-methylsimmondsin

2-[(1E)-2,3,4-trihydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexylidene]acetonitrile

C14H21NO9 (347.1216)


Dide-O-methylsimmondsin is found in coffee and coffee products. Dide-O-methylsimmondsin is a constituent of jojoba meal. Constituent of jojoba meal. Di-demethylsimmondsin is found in coffee and coffee products, fats and oils, and nuts.

   

1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine

17,18-dimethoxy-20-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(21),2,4(8),9,11,13,15,17,19-nonaene

C21H17NO4 (347.1158)


1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is found in fruits. 1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is an alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). Alkaloid from root bark of Zanthoxylum simulans (Szechuan pepper). 1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine is found in herbs and spices and fruits.

   

5'-Hydroxypiroxicam

4-Hydroxy-N-(5-hydroxypyridin-2-yl)-2-methyl-1,1-dioxo-2H-1λ⁶,2-benzothiazine-3-carboximidate

C15H13N3O5S (347.0576)


5-Hydroxypiroxicam is only found in individuals that have used or taken Piroxicam. 5-Hydroxypiroxicam is a metabolite of Piroxicam. 5-hydroxypiroxicam belongs to the family of Benzothiazines. These are organic compounds containing a benzene fused to a thiazine ring (a six-member ring with four carbon atoms, one nitrogen atom and one sulfur atom).

   

Embramine

{2-[1-(4-bromophenyl)-1-phenylethoxy]ethyl}dimethylamine

C18H22BrNO (347.0885)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Embramine is an ethanolamine H1-antihistamine.

   

Vidarabine phosphate

{[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7P (347.0631)


Adenosine monophosphate, also known as 5-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a Bitter Blocker additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem sweeter. This potentially makes lower calorie food products more palatable [HMDB] Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.

   

3-Phosphoadenosine

{9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-imino-6,9-dihydro-3H-purin-3-yl}phosphonic acid

C10H14N5O7P (347.0631)


   

5-Aminofluorescein

5-amino-3,6-dihydroxy-3H-spiro[2-benzofuran-1,9-xanthene]-3-one

C20H13NO5 (347.0794)


D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

2-(3,6,9-Trihydroxy-4-amino-9H-xanthene-9-yl)benzoic acid gamma-lactone

2-(3,6,9-Trihydroxy-4-amino-9H-xanthene-9-yl)benzoic acid gamma-lactone

C20H13NO5 (347.0794)


   

Zidovudine monophosphate

{[3-azido-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7P (347.0631)


   

N-Benzylglucamine dithiocarbamate

6-{benzyl[sulphanyl(carbonothioyl)]amino}hexane-1,2,3,4,5-pentol

C14H21NO5S2 (347.0861)


   

Desmethylofloxacin

7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C17H18FN3O4 (347.1281)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Eliprodil

1-(4-chlorophenyl)-2-{4-[(4-fluorophenyl)methyl]piperidin-1-yl}ethan-1-ol

C20H23ClFNO (347.1452)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Eliprodil(SL-820715) is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM). IC50 value: Target: NR2B-NMDA antagonist Human N-type Ca2+ channel currents were inhibited by ifenprodil and eliprodil with IC50 values of 50 microM and 10 microM respectively whereas P-type Ca2+ channel currents were inhibited reversibly by ifenprodil and eliprodil with approximate IC50 values of 60 microM and 9 microM respectively. eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8\% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9).

   

Kinetin riboside

Kinetin riboside

C15H17N5O5 (347.123)


   

Nafamostat

6-Carbamimidoylnaphthalen-2-yl 4-carbamimidamidobenzoic acid

C19H17N5O2 (347.1382)


D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D051056 - Complement Inactivating Agents COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Naproxcinod

4-(Nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl)propanoate

C18H21NO6 (347.1369)


   

Nizatidine sulfoxide

dimethyl({4-[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethanesulfinyl)methyl]-1,3-thiazol-2-yl}methyl)amine

C12H21N5O3S2 (347.1086)


   

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

C16H17N3O4S (347.094)


   

[(2R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate

[(2R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate

C10H14N5O7P (347.0631)


   

Leonurine HCl

4-Guanidinobutyl 4-hydroxy-3,5-diMethoxybenzoate hydrochloride 4-Hydroxy-3,5-dimethoxybenzoic acid 4-[(aminoiminomethyl)amino]butyl ester monohydrochloride

C14H21N3O5.HCl (347.1248)


Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.

   
   
   

11-Methoxylettowianthine

11-Methoxylettowianthine

C20H13NO5 (347.0794)


   
   
   
   
   
   
   

6alpha-Hydroxyundulatine

6alpha-Hydroxyundulatine

C18H21NO6 (347.1369)


   
   

CHEMBL1173138

CHEMBL1173138

C20H17N3O3 (347.127)


   

(+)-9-O-Demethylgalwesine

(+)-9-O-Demethylgalwesine

C18H21NO6 (347.1369)


   

2-carboxymethyl-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione

2-carboxymethyl-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione

C20H13NO5 (347.0794)


   

Clanobutin

Clanobutin

C18H18ClNO4 (347.0924)


C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents

   
   

5-Hydroxypiroxicam

5-Hydroxypiroxicam

C15H13N3O5S (347.0576)


   

Maybridge3_006129

Maybridge3_006129

C16H14FN3O3S (347.074)


   
   
   

Maybridge3_002375

Maybridge3_002375

C17H17NO5S (347.0827)


   

2-Deoxyguanosine 3-monophosphate

2-Deoxyguanosine 3-monophosphate

C10H14N5O7P (347.0631)


   

Kinetin-9-riboside

Kinetin-9-riboside

C15H17N5O5 (347.123)


   
   
   

(+)-4-(6-methoxy-9-methyl-8-oxo-8,9-dihydro-[1,3]dioxolo[4,5-h]quinolin-7-yl)-2-methyl-butyric acid methyl ester|Pteleolin|Pteleoline

(+)-4-(6-methoxy-9-methyl-8-oxo-8,9-dihydro-[1,3]dioxolo[4,5-h]quinolin-7-yl)-2-methyl-butyric acid methyl ester|Pteleolin|Pteleoline

C18H21NO6 (347.1369)


   

Ptelefructine

Ptelefructine

C18H21NO6 (347.1369)


   

7-Carboxyevodiamine

7-Carboxyevodiamine

C20H17N3O3 (347.127)


   
   
   

4-hydroxy-9-carboxynonenoic lactone mercapturic acid

4-hydroxy-9-carboxynonenoic lactone mercapturic acid

C14H21NO7S (347.1039)


   
   

desacetylsenaetin

desacetylsenaetin

C18H21NO6 (347.1369)


   

2-O-acetylcrinamabine

2-O-acetylcrinamabine

C18H21NO6 (347.1369)


   

(2S)-1-[(6,7-dimethoxyfuro[2,3-b]quinolin-4-yl)oxy]-3-methylbutane-2,3-diol

(2S)-1-[(6,7-dimethoxyfuro[2,3-b]quinolin-4-yl)oxy]-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

6-Hydroxyundulatine

6-Hydroxyundulatine

C18H21NO6 (347.1369)


   

Antrocinnamomin G

Antrocinnamomin G

C18H21NO6 (347.1369)


   

1,6-Dioxo-5-hydroxy-7-phenyl-1,2-dihydro-6H-benzo[de]isoquinoline-2-acetic acid

1,6-Dioxo-5-hydroxy-7-phenyl-1,2-dihydro-6H-benzo[de]isoquinoline-2-acetic acid

C20H13NO5 (347.0794)


   
   

hyrtioreticulin F

hyrtioreticulin F

C17H21N3O5 (347.1481)


   

Me glycoside,Me ester,N,1,2-tri-Ac-alpha-D-Pyranose-4-Amino-4-deoxyglucuronic acid

Me glycoside,Me ester,N,1,2-tri-Ac-alpha-D-Pyranose-4-Amino-4-deoxyglucuronic acid

C14H21NO9 (347.1216)


   

12-methoxynorchelerythrine

12-methoxynorchelerythrine

C20H13NO5 (347.0794)


   
   
   

8-hydroxyexophialin

8-hydroxyexophialin

C20H13NO5 (347.0794)


   

Dimorphamide C

Dimorphamide C

C17H17NO7 (347.1005)


   
   

(-)-circumdatin H|(5bS)-2-methoxy-5b,6,7,8-tetrahydro-10H,16H-pyrrolo[2,1-c]quinazolino[3,2-a]benzodiazepine-10,16-dione|(S)-(-)-circumdatin H|(S)-2-methoxy-5b,6,7,8-tetrahydrobenzo[6,7]pyrrolo[2,1:3,4][1,4]diazepino[2,1-b]quinazoline-10,16-dione|circumdatin H

(-)-circumdatin H|(5bS)-2-methoxy-5b,6,7,8-tetrahydro-10H,16H-pyrrolo[2,1-c]quinazolino[3,2-a]benzodiazepine-10,16-dione|(S)-(-)-circumdatin H|(S)-2-methoxy-5b,6,7,8-tetrahydrobenzo[6,7]pyrrolo[2,1:3,4][1,4]diazepino[2,1-b]quinazoline-10,16-dione|circumdatin H

C20H17N3O3 (347.127)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

10-Hydroxysanguinarine

10-Hydroxysanguinarine

C20H13NO5 (347.0794)


   
   

Leonurine HCl

4-Guanidinobutyl 4-hydroxy-3,5-diMethoxybenzoate hydrochloride 4-Hydroxy-3,5-dimethoxybenzoic acid 4-[(aminoiminomethyl)amino]butyl ester monohydrochloride

C14H22ClN3O5 (347.1248)


Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory. Leonurine hydrochloride is an alkaloid isolated from Leonurus artemisia, with anti-oxidative and anti-inflammatory.

   

Cefalexin

Cefalexin

C16H17N3O4S (347.094)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3014

   

Kinetin riboside

Kinetin-9-riboside

C15H17N5O5 (347.123)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins relative retention time with respect to 9-anthracene Carboxylic Acid is 0.645 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.646 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.642 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.644 Kinetin riboside, a cytokinin analog, can induce apoptosis in cancer cells. It inhibits the proliferation of HCT-15 cells with an IC50 of 2.5 μM.

   

2-Deoxy-5-Guanylic Acid

[(2R,5R)-5-(2-Amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H14N5O7P (347.0631)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.055

   

3-Adenylic acid

Adenosine 3-monophosphate From Yeast

C10H14N5O7P (347.0631)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.055 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056

   

KINETIN RIBOSIDE

NCGC00017361-03!KINETIN RIBOSIDE

C15H17N5O5 (347.123)


   

Adenosine 5-monophosphate

Adenosine-5-monophosphate sodium salt

C10H14N5O7P (347.0631)


Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.

   

2-Deoxyguanosine 5-monophosphate

2-Deoxyguanosine 5-monophosphate

C10H14N5O7P (347.0631)


A purine 2-deoxyribonucleoside 5-monophosphate having guanine as the nucleobase.

   

Adenosine-3-monophosphate

Adenosine-3-monophosphate

C10H14N5O7P (347.0631)


   

2-Adenylic acid

Adenosine-2-monophosphate

C10H14N5O7P (347.0631)


Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2]. Adenosine-2'-monophosphate (2'-AMP) is converted by extracellular 2’,3'-CAMP. Adenosine-2'-monophosphate is further metabolized to extracellular adenosine (a mechanism called the extracellular 2’,3’-cAMP-adenosine pathway). Adenosine-2'-monophosphate inhibits LPS-induced TNF-α and CXCL10 production via A2A receptor activation[1][2].

   

Deoxyguanosine 5-monophosphate

Deoxyguanosine 5-monophosphate

C10H14N5O7P (347.0631)


   

Adenosine monophosphate

Adenosine monophosphate

C10H14N5O7P (347.0631)


   

Deoxyguanylic acid

Deoxyguanylic acid

C10H14N5O7P (347.0631)


   

Chloroaustralasine B

Chloroaustralasine B

C19H22ClNO3 (347.1288)


   
   

Oxysanguinarine

Oxysanguinarine

C20H13NO5 (347.0794)


   
   

AMP; LC-tDDA; CE10

AMP; LC-tDDA; CE10

C10H14N5O7P (347.0631)


   

AMP; LC-tDDA; CE20

AMP; LC-tDDA; CE20

C10H14N5O7P (347.0631)


   

AMP; LC-tDDA; CE30

AMP; LC-tDDA; CE30

C10H14N5O7P (347.0631)


   

AMP; LC-tDDA; CE40

AMP; LC-tDDA; CE40

C10H14N5O7P (347.0631)


   

DEOXYGUANOSINE-MONOPHOSPHATE

DEOXYGUANOSINE-MONOPHOSPHATE

C10H14N5O7P (347.0631)


   

Adenosine-monophosphate

Adenosine-monophosphate

C10H14N5O7P (347.0631)


   

8-2-Amino-3-methylimidazo[4,5-f]quinoline-guanine

8-2-Amino-3-methylimidazo[4,5-f]quinoline-guanine

C16H13N9O1 (347.1243)


   

N2-(Furan-2-yl)methyl-deoxyguanosine

N2-(Furan-2-yl)methyl-deoxyguanosine

C15H17N5O5 (347.123)


   

Cephalexin

Cephalexin - Dark Web Drugs

C16H17N3O4S (347.094)


A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

5-Adenylic acid

[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H14N5O7P (347.0631)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites

   

Ala Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Ala Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Ala Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Ala Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O7 (347.1441)


   

Ala Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Ala Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O7 (347.1441)


   

Gly Ala Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Gly Ala Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Gly Gly Asn Thr

(2S,3R)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C12H21N5O7 (347.1441)


   

Gly Gly Gln Ser

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Gly Gly Ser Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C12H21N5O7 (347.1441)


   

Gly Gly Thr Asn

(2S)-2-[(2S,3R)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Gly Asn Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Gly Asn Gly Thr

(2S,3R)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}-3-hydroxybutanoic acid

C12H21N5O7 (347.1441)


   

Gly Asn Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]propanoic acid

C12H21N5O7 (347.1441)


   

Gly Asn Thr Gly

2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanamido]acetic acid

C12H21N5O7 (347.1441)


   

Gly Gln Gly Ser

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Gly Gln Ser Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O7 (347.1441)


   

Gly Ser Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]propanamido]-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Gly Ser Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]acetamido}-4-carbamoylbutanoic acid

C12H21N5O7 (347.1441)


   

Gly Ser Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]propanoic acid

C12H21N5O7 (347.1441)


   

Gly Ser Gln Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanamido]acetic acid

C12H21N5O7 (347.1441)


   

Gly Thr Gly Asn

(2S)-2-{2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Gly Thr Asn Gly

2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O7 (347.1441)


   
   
   

Nizatidine sulfoxide

Nizatidine sulfoxide

C12H21N5O3S2 (347.1086)


   
   

N-Formylnorfloxacin

N-Formylnorfloxacin

C17H18FN3O4 (347.1281)


   

Desmethylofloxacin

N-Demethylofloxacin

C17H18FN3O4 (347.1281)


   
   
   

Asn Ala Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Asn Ala Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O7 (347.1441)


   

Asn Gly Ala Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Asn Gly Gly Thr

(2S,3R)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)-3-hydroxybutanoic acid

C12H21N5O7 (347.1441)


   

Asn Gly Ser Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]propanoic acid

C12H21N5O7 (347.1441)


   

Asn Gly Thr Gly

2-[(2S,3R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxybutanamido]acetic acid

C12H21N5O7 (347.1441)


   

Asn Ser Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]propanamido]acetic acid

C12H21N5O7 (347.1441)


   

Asn Ser Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}propanoic acid

C12H21N5O7 (347.1441)


   

Asn Thr Gly Gly

2-{2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]acetamido}acetic acid

C12H21N5O7 (347.1441)


   
   

p-HydroxyPiroxicam

p-HydroxyPiroxicam

C15H13N3O5S (347.0576)


   

Gln Gly Gly Ser

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)-3-hydroxypropanoic acid

C12H21N5O7 (347.1441)


   

Gln Gly Ser Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxypropanamido]acetic acid

C12H21N5O7 (347.1441)


   
   

Gln Ser Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]acetamido}acetic acid

C12H21N5O7 (347.1441)


   
   

Ser Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Ser Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O7 (347.1441)


   
   

Ser Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Ser Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C12H21N5O7 (347.1441)


   

Ser Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C12H21N5O7 (347.1441)


   

Ser Gly Gln Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C12H21N5O7 (347.1441)


   

Ser Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C12H21N5O7 (347.1441)


   

Ser Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C12H21N5O7 (347.1441)


   

Ser Gln Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C12H21N5O7 (347.1441)


   

Thr Gly Gly Asn

(2S)-2-(2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

C12H21N5O7 (347.1441)


   

Thr Gly Asn Gly

2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carbamoylpropanamido]acetic acid

C12H21N5O7 (347.1441)


   

Thr Asn Gly Gly

2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]acetamido}acetic acid

C12H21N5O7 (347.1441)


   

Zidovudine monophosphate

Zidovudine monophosphate

C10H14N5O7P (347.0631)


   
   
   
   
   

1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine

17,18-dimethoxy-20-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{14,19}]henicosa-1(13),2,4(8),9,11,14,16,18,20-nonaene

C21H17NO4 (347.1158)


   

Pamabrom

Pamabrom

C11H18BrN5O3 (347.0593)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic

   

Pyrido[2,3-b][1,6]naphthyridine, 7-[2-(acetyloxy)benzoyl]-6,7,8,9-tetrahydro- (9CI)

Pyrido[2,3-b][1,6]naphthyridine, 7-[2-(acetyloxy)benzoyl]-6,7,8,9-tetrahydro- (9CI)

C20H17N3O3 (347.127)


   

3-[BENZYL-(TOLUENE-4-SULFONYL)-AMINO]-2-METHYL-PROPIONIC ACID

3-[BENZYL-(TOLUENE-4-SULFONYL)-AMINO]-2-METHYL-PROPIONIC ACID

C18H21NO4S (347.1191)


   

1-naphthyl-n-acetyl-beta-d-glucosaminide

1-Naphthyl 2-acetamido-2-deoxy-beta-D-glucopyranoside

C18H21NO6 (347.1369)


   

5-Pyrimidinecarbonitrile, 4-amino-2-(2,5-dihydroxyphenyl)-6-(3-piperidinyl)-, (HCl salt)

5-Pyrimidinecarbonitrile, 4-amino-2-(2,5-dihydroxyphenyl)-6-(3-piperidinyl)-, (HCl salt)

C16H18ClN5O2 (347.1149)


   

Thiazolidine, 3-[(2,4-dimethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(2,4-dimethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C18H21NO2S2 (347.1014)


   

Desmethyl levofloxacin

N-Desmethyl levofloxacin

C17H18FN3O4 (347.1281)


   

o-mono-2,4-dnp-l-tyrosine

o-mono-2,4-dnp-l-tyrosine

C15H13N3O7 (347.0753)


   

Thiazolidine, 3-[(4-ethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-ethylphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C18H21NO2S2 (347.1014)


   

5(6)-Aminofluorescein

5(6)-Aminofluorescein

C20H13NO5 (347.0794)


   

4-(Benzoylamino)-2,5-diethoxybenzenediazonium chloride

4-(Benzoylamino)-2,5-diethoxybenzenediazonium chloride

C17H18ClN3O3 (347.1037)


   

3,5-Diphenyl-4-(1-naphthyl)-1H-1,2,4-triazole

3,5-Diphenyl-4-(1-naphthyl)-1H-1,2,4-triazole

C24H17N3 (347.1422)


   
   
   

diethyl 2-(trifluoromethoxy)phenylamino-n-methylenemalonate

diethyl 2-(trifluoromethoxy)phenylamino-n-methylenemalonate

C15H16F3NO5 (347.0981)


   

Boc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

Boc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

C16H20F3NO4 (347.1344)


   

Boc-(S)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid

C16H20F3NO4 (347.1344)


   
   

5-(N-(4-butylphenyl)sulfamoyl)-2-Methylbenzoic acid

5-(N-(4-butylphenyl)sulfamoyl)-2-Methylbenzoic acid

C18H21NO4S (347.1191)


   

5-(3-AMINO-5-OXO-2-PYRAZOLIN-1-YL)-2-PHENOXYBENZENESULFONIC ACID

5-(3-AMINO-5-OXO-2-PYRAZOLIN-1-YL)-2-PHENOXYBENZENESULFONIC ACID

C15H13N3O5S (347.0576)


   
   

1-METHYL-4-(PHENYLAZO)-QUINOLINIUM PERCHLORATE

1-METHYL-4-(PHENYLAZO)-QUINOLINIUM PERCHLORATE

C16H14ClN3O4 (347.0673)


   

Vidarabine phosphate

Vidarabine phosphate

C10H14N5O7P (347.0631)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D009676 - Noxae > D000963 - Antimetabolites Vidarabine phosphate (Ara-AMP), an antiviral agent, inhibits chronic HBV infection[1][2]. Vidarabine phosphate also against herpes simplex and varicella zoster viruses[3].

   
   

Boc-(R)-3-amino-4-(2-trifluoromethylphenyl)-butyric acid

Boc-(R)-3-amino-4-(2-trifluoromethylphenyl)-butyric acid

C16H20F3NO4 (347.1344)


   

2-(4-biphenylyl)-6-phenylbenzoxazole

2-(4-biphenylyl)-6-phenylbenzoxazole

C25H17NO (347.131)


   

3-(3,4-Dimethoxy-benzoylamino)-3-(4-fluoro-phenyl)-propionic acid

3-(3,4-Dimethoxy-benzoylamino)-3-(4-fluoro-phenyl)-propionic acid

C18H18FNO5 (347.1169)


   

4-(Benzyloxy)-5-bromo-2-(piperidin-1-yl)pyrimidine

4-(Benzyloxy)-5-bromo-2-(piperidin-1-yl)pyrimidine

C16H18BrN3O (347.0633)


   
   

6-tert-Butyl-4-methyl-2-[(4-chloro-2-nitrophenyl)azo]phenol

6-tert-Butyl-4-methyl-2-[(4-chloro-2-nitrophenyl)azo]phenol

C17H18ClN3O3 (347.1037)


   

Bicyclo[2.2.1]heptan-2-amine,N-[(4-chlorophenyl)phenylmethyl]-, hydrochloride (1:1)

Bicyclo[2.2.1]heptan-2-amine,N-[(4-chlorophenyl)phenylmethyl]-, hydrochloride (1:1)

C20H23Cl2N (347.1207)


   

b-D-Glucopyranosylamine,2,3,4,6-tetraacetate

b-D-Glucopyranosylamine,2,3,4,6-tetraacetate

C14H21NO9 (347.1216)


   

1-ETHYNYL-4-((4-((4-NITROPHENYL)ETHYNYL)PHENYL)ETHYNYL)BENZENE

1-ETHYNYL-4-((4-((4-NITROPHENYL)ETHYNYL)PHENYL)ETHYNYL)BENZENE

C24H13NO2 (347.0946)


   

[2-(6-aminopurin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate

[2-(6-aminopurin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate

C10H14N5O7P (347.0631)


   

6-Aminofluorescein

6-Aminofluorescein

C20H13NO5 (347.0794)


   

ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE

ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE

C18H21NO4S (347.1191)


   

2H-Pyrrol-2-one, 4-acetyl-1-(3-chloro-4-methylphenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-1-(3-chloro-4-methylphenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-

C19H22ClNO3 (347.1288)


   

6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine

6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine

C19H22ClNO3 (347.1288)


   

Boc-(R)-3-amino-4-(2,4-dichlorophenyl)butyric acid

Boc-(R)-3-amino-4-(2,4-dichlorophenyl)butyric acid

C15H19Cl2NO4 (347.0691)


   

Boc-(R)-3-amino-4-(4-trifluoromethylphenyl)-butyric acid

Boc-(R)-3-amino-4-(4-trifluoromethylphenyl)-butyric acid

C16H20F3NO4 (347.1344)


   

Boc-(S)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid

Boc-(S)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid

C16H20F3NO4 (347.1344)


   

Boc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

Boc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

C15H19Cl2NO4 (347.0691)


   

Boc-(S)-3-Amino-4-(3-trifluoromethyl-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(3-trifluoromethyl-phenyl)-butyric acid

C16H20F3NO4 (347.1344)


   

2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE

2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE

C17H22BNO4S (347.1363)


   
   

Methanone, [4-(5-chloro-2-methylphenyl)-1-piperazinyl](3-ethyl-5-methyl-4-isoxazolyl)

Methanone, [4-(5-chloro-2-methylphenyl)-1-piperazinyl](3-ethyl-5-methyl-4-isoxazolyl)

C18H22ClN3O2 (347.14)


   

Methanone, [4-(3-chlorophenyl)-1-piperazinyl][3-methyl-5-(1-methylethyl)-4-isoxazolyl]

Methanone, [4-(3-chlorophenyl)-1-piperazinyl][3-methyl-5-(1-methylethyl)-4-isoxazolyl]

C18H22ClN3O2 (347.14)


   

6-AMINO-1-[3-(CYCLOPENTYLOXY)-4-METHOXYBENZYL]-2-THIOXO-2,3-DIHYDROPYRIMIDIN-4(1H)-ONE

6-AMINO-1-[3-(CYCLOPENTYLOXY)-4-METHOXYBENZYL]-2-THIOXO-2,3-DIHYDROPYRIMIDIN-4(1H)-ONE

C17H21N3O3S (347.1304)


   

Prasugrel Hydroxy Thiolactone

Prasugrel Hydroxy Thiolactone

C18H18FNO3S (347.0991)


   

methyl 2,3-dihydro-2-(3-hydroxy-2-quinolyl)-1,3-dioxo-1H-indene-5-carboxylate

methyl 2,3-dihydro-2-(3-hydroxy-2-quinolyl)-1,3-dioxo-1H-indene-5-carboxylate

C20H13NO5 (347.0794)


   

Sulbactam pivoxil

Sulbactam pivoxil

C14H21NO7S (347.1039)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor

   

PFI-1

2-Methoxy-N-(3-Methyl-2-Oxo-1,2,3,4-Tetrahydroquinazolin-6-Yl)benzenesulfonamide

C16H17N3O4S (347.094)


   
   

4-[[(4-tert-butylphenyl)sulfonylamino]methyl]benzoic acid

4-[[(4-tert-butylphenyl)sulfonylamino]methyl]benzoic acid

C18H21NO4S (347.1191)


   

1-benzyl-4-(2-methoxy-phenyl)-pyrrolidine-3-carboxylic acid hydrochloride

1-benzyl-4-(2-methoxy-phenyl)-pyrrolidine-3-carboxylic acid hydrochloride

C19H22ClNO3 (347.1288)


   

trans-1-Benzyl-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid

trans-1-Benzyl-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid

C19H22ClNO3 (347.1288)


   

6-[5-({[2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-ol

6-[5-({[2-(methylsulphonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-ol

C16H17N3O4S (347.094)


   

New methylene blue

New methylene blue

C18H22ClN3S (347.1223)


   

Boc-(R)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

Boc-(R)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

C15H19Cl2NO4 (347.0691)


   

(2R,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-aminotetrahydro-2H-pyran-3,4,5-triyl triacetate

(2R,3S,4S,5R,6R)-2-(Acetoxymethyl)-6-aminotetrahydro-2H-pyran-3,4,5-triyl triacetate

C14H21NO9 (347.1216)


   

CCT036477

N-[(4-chlorophenyl)-(2-methyl-1H-indol-3-yl)methyl]pyridin-2-amine

C21H18ClN3 (347.1189)


   

ethyl 2-piperazine-4-(4-methoxy)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(4-methoxy)phenyl thiazole-5-carboxylate

C17H21N3O3S (347.1304)


   

Hexaamminecobalt(III) nitrate

Hexaamminecobalt(III) nitrate

CoH18N9O9 (347.0559)


   

1,9-dimethylmethylene blue

1,9-dimethylmethylene blue

C18H22ClN3S (347.1223)


   

7-(PHENYLACETAMIDO)-4-(TRIFLUOROMETHYL)COUMARIN

7-(PHENYLACETAMIDO)-4-(TRIFLUOROMETHYL)COUMARIN

C18H12F3NO3 (347.0769)


   

Phthaloyl-L- alanyl-L-glutamine

Phthaloyl-L- alanyl-L-glutamine

C16H17N3O6 (347.1117)


   

Boc-(S)-3-amino-4-(2,4-dichlorophenyl)butyric acid

Boc-(S)-3-amino-4-(2,4-dichlorophenyl)butyric acid

C15H19Cl2NO4 (347.0691)


   

Ciprofloxacin EP IMpurity D

Ciprofloxacin EP IMpurity D

C17H18ClN3O3 (347.1037)


   

N-[(2S)-3-Amino-2-hydroxypropyl]-N-[3-fluoro-4-(4-morpholinyl)phenyl]acetamide hydrochloride (1:1)

N-[(2S)-3-Amino-2-hydroxypropyl]-N-[3-fluoro-4-(4-morpholinyl)phenyl]acetamide hydrochloride (1:1)

C15H23ClFN3O3 (347.1412)


   
   

Benzyl 2-(methylsulfonyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate

Benzyl 2-(methylsulfonyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate

C16H17N3O4S (347.094)


   

3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE

3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-TOSYL-1H-PYRROLE

C17H22BNO4S (347.1363)


   

2-(1,4-Diazepan-1-yl)-1,3-benzothiazoletrifluoroacetic acid salt

2-(1,4-Diazepan-1-yl)-1,3-benzothiazoletrifluoroacetic acid salt

C14H16F3N3O2S (347.0915)


   

Cephalexin Diketopiperazine

Cephalexin Diketopiperazine

C16H17N3O4S (347.094)


   

nalorphine hydrochloride ciii (250 mg)

nalorphine hydrochloride ciii (250 mg)

C19H22ClNO3 (347.1288)


   

naproxcinod

naproxcinod

C18H21NO6 (347.1369)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

L-779450

2-chloro-5-(2-phenyl-5-(pyridin-4-yl)-1H-imidazol-4-yl)phenol

C20H14ClN3O (347.0825)


L-779450 is a potent and selective B-Raf kinase inhibitor with a Kd of 2.4 nM.

   

Formycin-5-monophosphate

Formycin-5-monophosphate

C10H14N5O7P (347.0631)


D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D005573 - Formycins

   

2-Deoxyguanosine 3-(dihydrogen phosphate)

2-Deoxyguanosine 3-(dihydrogen phosphate)

C10H14N5O7P (347.0631)


   

5-(Carboxymethylaminomethyl)-2-thiouridine

5-(Carboxymethylaminomethyl)-2-thiouridine

C12H17N3O7S (347.0787)


   
   

Circumdatin H

Circumdatin H

C20H17N3O3 (347.127)


An organic heteropentacyclic compound that is 5b,7,8,16-tetrahydro-6H,10H-pyrrolo[2,1-c]quinazolino[3,2-a][1,4]benzodiazepine substituted by a methoxy group at position 2 and oxo groups at positions 10 and 16 (the 5bS stereoisomer). An alkaloid isolated from the culture broth of Aspergillus ochraceus, it exhibits potent inhibitory activity towards mitochondrial NADH oxidase.

   
   

(+)-(S)-Eliprodil

(+)-(S)-Eliprodil

C20H23ClFNO (347.1452)


   

4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester

4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester

C16H17N3O4S (347.094)


   

2-[3-(3,4-Dimethoxyphenyl)pyrazolo[1,5-a]pyrimidin-5-yl]benzenol

2-[3-(3,4-Dimethoxyphenyl)pyrazolo[1,5-a]pyrimidin-5-yl]benzenol

C20H17N3O3 (347.127)


   

N-[1-(4-methyl-6-oxo-1-pyrimidinyl)-2-oxo-2-phenylethyl]benzamide

N-[1-(4-methyl-6-oxo-1-pyrimidinyl)-2-oxo-2-phenylethyl]benzamide

C20H17N3O3 (347.127)


   

N-[2-(3-oxo-4H-quinoxalin-2-yl)phenyl]-2-thiophenecarboxamide

N-[2-(3-oxo-4H-quinoxalin-2-yl)phenyl]-2-thiophenecarboxamide

C19H13N3O2S (347.0728)


   

N2-(2-methoxyphenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

N2-(2-methoxyphenyl)-6-(3-methyl-2-benzofuranyl)-1,3,5-triazine-2,4-diamine

C19H17N5O2 (347.1382)


   

1-phenyl-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]-1H-imidazole-5-carboxamide

1-phenyl-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]-1H-imidazole-5-carboxamide

C18H13N5OS (347.0841)


   

N-(biphenyl-4-ylsulfonyl)-D-leucine

N-(biphenyl-4-ylsulfonyl)-D-leucine

C18H21NO4S (347.1191)


   

(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol

(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol

C18H21NO6 (347.1369)


   

alpha-Adenosine monophosphate

alpha-Adenosine monophosphate

C10H14N5O7P (347.0631)


   

7-alpha-D-Ribofuranosyl-2-aminopurine-5-phosphate

7-alpha-D-Ribofuranosyl-2-aminopurine-5-phosphate

C10H14N5O7P (347.0631)


   

delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine

delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine

C13H21N3O6S (347.1151)


   

Nafamostat

Nafamostat

C19H17N5O2 (347.1382)


D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D051056 - Complement Inactivating Agents COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Embramine

Embramine

C18H22BrNO (347.0885)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

BSPBio_000729

(2R)-1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(2R,3R,4S,5R)-2-[6-(furan-2-ylmethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

(2R,3R,4S,5R)-2-[6-(furan-2-ylmethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H17N5O5 (347.123)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins

   

N-Benzylglucamine dithiocarbamate

6-{benzyl[sulphanyl(carbonothioyl)]amino}hexane-1,2,3,4,5-pentol

C14H21NO5S2 (347.0861)


   

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

(4R)-4-Hydroxy-4-[6-[(5R)-5-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-1,3-benzothiazol-2-yl]butanenitrile

C16H17N3O4S (347.094)


   

8-hydroxy-dAMP

8-hydroxy-dAMP

C10H14N5O7P (347.0631)


A purine 2-deoxyribonucleoside 5-monophosphate that is that is dAMP in which the hydrogen at position 8 of the purine base has been replaced by a hydroxy group.

   

(1E,2Z)-3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate

(1E,2Z)-3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate

C19H23O6- (347.1495)


   
   
   

(1R,2R,5R,8R,9S,10R,11R,12R,13S)-12,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5R,8R,9S,10R,11R,12R,13S)-12,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O6- (347.1495)


   

(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O6- (347.1495)


   
   

(1R,2R,5S,8S,9S,10R,11S,13R)-5,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5S,8S,9S,10R,11S,13R)-5,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O6- (347.1495)


   

16alpha,17-epoxy gibberellin A4

16alpha,17-epoxy gibberellin A4

C19H23O6- (347.1495)


   

s-Allylglutathione

s-Allylglutathione

C13H21N3O6S (347.1151)


   

L-methionyl-3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine

L-methionyl-3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine

C13H21N3O6S (347.1151)


   

[5-(7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[5-(7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H14N5O7P (347.0631)


   

L-Met-3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-OH

L-Met-3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-OH

C13H21N3O6S (347.1151)


   

1,1-Ethenediamine, N-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-

1,1-Ethenediamine, N-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-

C12H21N5O3S2 (347.1086)


   

[9-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-iminopurin-3-yl]phosphonic acid

[9-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-iminopurin-3-yl]phosphonic acid

C10H14N5O7P (347.0631)


   

gibberellin A1(1-)

gibberellin A1(1-)

C19H23O6- (347.1495)


Conjugate base of gibberellin A1.

   

Adenosine 5-Monophosphate

Adenosine 5-Monophosphate

C10H14N5O7P (347.0631)


   

1-(3,4-Dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea

1-(3,4-Dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea

C16H17N3O6 (347.1117)


   

N-{5-chloro-2-nitrobenzylidene}-4-ethoxybenzohydrazide

N-{5-chloro-2-nitrobenzylidene}-4-ethoxybenzohydrazide

C16H14ClN3O4 (347.0673)


   

4-chloro-N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)benzamide

4-chloro-N-(4-imidazo[1,2-a]pyridin-2-ylphenyl)benzamide

C20H14ClN3O (347.0825)


   

4-Amino-5,8-dimethoxy-2-(1,1,2,2,2-pentafluoroethyl)-3-quinolinecarbonitrile

4-Amino-5,8-dimethoxy-2-(1,1,2,2,2-pentafluoroethyl)-3-quinolinecarbonitrile

C14H10F5N3O2 (347.0693)


   

Acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester

Acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester

C17H17NO5S (347.0827)


   

N-[[(6-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-4-phenylbenzamide

N-[[(6-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-4-phenylbenzamide

C20H17N3OS (347.1092)


   

[2-(Methylthio)phenyl]-[1-[oxo(4-thiadiazolyl)methyl]-3-piperidinyl]methanone

[2-(Methylthio)phenyl]-[1-[oxo(4-thiadiazolyl)methyl]-3-piperidinyl]methanone

C16H17N3O2S2 (347.0762)


   

(1-Methyl-3-indolyl)-diphenyl-sulfanylidenephosphorane

(1-Methyl-3-indolyl)-diphenyl-sulfanylidenephosphorane

C21H18NPS (347.0898)


   

1-[4-(3,5-Dimethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(3,5-Dimethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

C17H21N3O3S (347.1304)


   
   

3-(3-Amino-3-carboxypropyl)-5,6-dihydrouridine

3-(3-Amino-3-carboxypropyl)-5,6-dihydrouridine

C13H21N3O8 (347.1329)


   

gibberellin A34(1-)

gibberellin A34(1-)

C19H23O6- (347.1495)


   

1-(2-Chloro-4-nitrophenyl)-4-(2-methoxyphenyl)piperazine

1-(2-Chloro-4-nitrophenyl)-4-(2-methoxyphenyl)piperazine

C17H18ClN3O3 (347.1037)


   

N-(1,1-dioxo-2,3-dihydrothiophen-3-yl)-N-(2-ethylphenyl)-2-thiophenecarboxamide

N-(1,1-dioxo-2,3-dihydrothiophen-3-yl)-N-(2-ethylphenyl)-2-thiophenecarboxamide

C17H17NO3S2 (347.065)


   

1-(3-Methoxyphenyl)-3-[5-(2-methyl-1-piperidinyl)-1,3,4-thiadiazol-2-yl]urea

1-(3-Methoxyphenyl)-3-[5-(2-methyl-1-piperidinyl)-1,3,4-thiadiazol-2-yl]urea

C16H21N5O2S (347.1416)


   

N-[(R)-[(1R,2R)-2-butylcyclopropyl]-(4-chlorophenyl)methyl]-2-thiophenecarboxamide

N-[(R)-[(1R,2R)-2-butylcyclopropyl]-(4-chlorophenyl)methyl]-2-thiophenecarboxamide

C19H22ClNOS (347.1111)


   

1-[2-(Dimethylamino)ethyl]-3-(2,4-dimethylphenyl)-1-(thiophen-2-ylmethyl)thiourea

1-[2-(Dimethylamino)ethyl]-3-(2,4-dimethylphenyl)-1-(thiophen-2-ylmethyl)thiourea

C18H25N3S2 (347.149)


   

6-(3-methoxyphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

6-(3-methoxyphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C20H17N3OS (347.1092)


   

3-[[[3-(4-Methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acid

3-[[[3-(4-Methoxyphenyl)phenyl]-oxomethyl]amino]benzoic acid

C21H17NO4 (347.1158)


   

6-Amino-5-cyano-2-phenyl-4-pyridin-4-yl-4H-pyran-3-carboxylic acid ethyl ester

6-Amino-5-cyano-2-phenyl-4-pyridin-4-yl-4H-pyran-3-carboxylic acid ethyl ester

C20H17N3O3 (347.127)


   

1-[[(4-Ethyl-5-methyl-3-thiophenyl)-oxomethyl]amino]-3-(2-phenylethyl)thiourea

1-[[(4-Ethyl-5-methyl-3-thiophenyl)-oxomethyl]amino]-3-(2-phenylethyl)thiourea

C17H21N3OS2 (347.1126)


   

N-[4-(4-acetyl-1-piperazinyl)-3-chlorophenyl]-2-furancarboxamide

N-[4-(4-acetyl-1-piperazinyl)-3-chlorophenyl]-2-furancarboxamide

C17H18ClN3O3 (347.1037)


   

N-(2,5-dimethoxyphenyl)-4-(2,4-dimethyl-5-thiazolyl)-2-thiazolamine

N-(2,5-dimethoxyphenyl)-4-(2,4-dimethyl-5-thiazolyl)-2-thiazolamine

C16H17N3O2S2 (347.0762)


   

2-Chloro-5-[[2,3-dihydro-1,4-benzodioxin-3-yl(oxo)methyl]amino]benzoic acid methyl ester

2-Chloro-5-[[2,3-dihydro-1,4-benzodioxin-3-yl(oxo)methyl]amino]benzoic acid methyl ester

C17H14ClNO5 (347.056)


   

6-(2-Furanyl)-3-methyl-1-phenyl-4-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester

6-(2-Furanyl)-3-methyl-1-phenyl-4-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester

C20H17N3O3 (347.127)


   

6-Chloro-4-[[(2-fluorophenyl)methyl-methylamino]methyl]-7-hydroxy-1-benzopyran-2-one

6-Chloro-4-[[(2-fluorophenyl)methyl-methylamino]methyl]-7-hydroxy-1-benzopyran-2-one

C18H15ClFNO3 (347.0724)


   

[2-(Methylamino)-2-oxoethyl] 1-(4-fluorophenyl)-3-methylthieno[2,3-c]pyrazole-5-carboxylate

[2-(Methylamino)-2-oxoethyl] 1-(4-fluorophenyl)-3-methylthieno[2,3-c]pyrazole-5-carboxylate

C16H14FN3O3S (347.074)


   

3-(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)-N-(3-fluoro-4-methylphenyl)propanamide

3-(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)-N-(3-fluoro-4-methylphenyl)propanamide

C16H14FN3O3S (347.074)


   

5-[[3-Methyl-1-(4-methylphenyl)-5-oxo-4-pyrazolylidene]methylamino]-1,3-dihydrobenzimidazol-2-one

5-[[3-Methyl-1-(4-methylphenyl)-5-oxo-4-pyrazolylidene]methylamino]-1,3-dihydrobenzimidazol-2-one

C19H17N5O2 (347.1382)


   

N-[(4-tert-butylcyclohexylidene)amino]-3-chloro-5-(trifluoromethyl)-2-pyridinamine

N-[(4-tert-butylcyclohexylidene)amino]-3-chloro-5-(trifluoromethyl)-2-pyridinamine

C16H21ClF3N3 (347.1376)


   

N-[1-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)ethyl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)urea

N-[1-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)ethyl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)urea

C15H17N5O3S (347.1052)


   

3-(6-Methylpyridin-2-yl)-2-(4-pyridin-3-ylphenyl)-1,3-thiazolidin-4-one

3-(6-Methylpyridin-2-yl)-2-(4-pyridin-3-ylphenyl)-1,3-thiazolidin-4-one

C20H17N3OS (347.1092)


   

Met-FMDP

Met-FMDP

C13H21N3O6S (347.1151)


A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-methionine joined by peptide linkages.

   
   
   
   

2-amino-9-(2-deoxy-5-O-phosphono-beta-L-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one

2-amino-9-(2-deoxy-5-O-phosphono-beta-L-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one

C10H14N5O7P (347.0631)


   

N-[3-(dimethylamino)propyl]-N-(4-fluoro-1,3-benzothiazol-2-yl)-2-furancarboxamide

N-[3-(dimethylamino)propyl]-N-(4-fluoro-1,3-benzothiazol-2-yl)-2-furancarboxamide

C17H18FN3O2S (347.1104)


   

2-[2-Fluoro-4-chloro-5-[(S)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione

2-[2-Fluoro-4-chloro-5-[(S)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione

C18H15ClFNO3 (347.0724)


   

2-[2-Fluoro-4-chloro-5-[(R)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione

2-[2-Fluoro-4-chloro-5-[(R)-1-methyl-2-propynyloxy]phenyl]-4,5,6,7-tetrahydro-2H-isoindole-1,3-dione

C18H15ClFNO3 (347.0724)


   

8-Amino-9-benzoyl-5-oxa-7-thia-cyclohepta[a]naphthalen-6-one

8-Amino-9-benzoyl-5-oxa-7-thia-cyclohepta[a]naphthalen-6-one

C20H13NO3S (347.0616)


   

5-dioxooctahydro-1H-inden-4-yl]-6-oxoocta-2,4-dienoate

5-dioxooctahydro-1H-inden-4-yl]-6-oxoocta-2,4-dienoate

C19H23O6- (347.1495)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

O-(alpha-D-mannose-1-phosphoryl)-L-serine

O-(alpha-D-mannose-1-phosphoryl)-L-serine

C9H18NO11P (347.0617)


   

3-[(2,5-Dimethoxyphenyl)iminomethyl]-1,5-dioxaspiro[5.5]undecane-2,4-dione

3-[(2,5-Dimethoxyphenyl)iminomethyl]-1,5-dioxaspiro[5.5]undecane-2,4-dione

C18H21NO6 (347.1369)


   

5-[(E)-[[7-(hydroxyamino)-7-oxoheptanoyl]hydrazinylidene]methyl]furan-2-sulfonic acid

5-[(E)-[[7-(hydroxyamino)-7-oxoheptanoyl]hydrazinylidene]methyl]furan-2-sulfonic acid

C12H17N3O7S (347.0787)


   

2-[1-(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)ethyl]-N-phenylhydrazinecarbothioamide

2-[1-(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)ethyl]-N-phenylhydrazinecarbothioamide

C15H17N5O3S (347.1052)


   

Butyl N-trifluoroacetyl 2-N-methylaminoethyl phosphonate

Butyl N-trifluoroacetyl 2-N-methylaminoethyl phosphonate

C13H25F3NO4P (347.1473)


   

Dibutyl 1-(N-trifuoroacetylamino)propylphosphonate

Dibutyl 1-(N-trifuoroacetylamino)propylphosphonate

C13H25F3NO4P (347.1473)


   

2 inverted exclamation marka-Deoxy-N-(2-furanylmethyl)guanosine

2 inverted exclamation marka-Deoxy-N-(2-furanylmethyl)guanosine

C15H17N5O5 (347.123)


   

[(2S,3R,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2S,3R,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H14N5O7P (347.0631)


   

dicyanide

24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-one

C20H13NO5 (347.0794)


Hydroxysanguinarine is a benzophenanthridine alkaloid. Hydroxysanguinarine is a natural product found in Fumaria indica, Fumaria parviflora, and other organisms with data available.

   

Adenosine phosphate

Adenosine 5-monophosphate

C10H14N5O7P (347.0631)


A purine ribonucleoside 5-monophosphate having adenine as the nucleobase. COVID info from PDB, Protein Data Bank, COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction. Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.

   
   
   

7-(5-phospho-alpha-D-ribosyl)adenine

7-(5-phospho-alpha-D-ribosyl)adenine

C10H14N5O7P (347.0631)


   

Eliprodil

Eliprodil

C20H23ClFNO (347.1452)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Eliprodil(SL-820715) is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM). IC50 value: Target: NR2B-NMDA antagonist Human N-type Ca2+ channel currents were inhibited by ifenprodil and eliprodil with IC50 values of 50 microM and 10 microM respectively whereas P-type Ca2+ channel currents were inhibited reversibly by ifenprodil and eliprodil with approximate IC50 values of 60 microM and 9 microM respectively. eliprodil (1 microm) produced a moderate reverse rate-dependent prolongation of the action potential duration (7.4+/-1.5, 8.9+/-2.1 and 9.9+/-1.8\% at cycle lengths of 300, 1000 and 5000 ms, respectively; n=9).

   

5-Aminofluorescein

5-Aminofluorescein

C20H13NO5 (347.0794)


D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

Dide-O-methylsimmondsin

Dide-O-methylsimmondsin

C14H21NO9 (347.1216)


   

(2R)-1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-methylbutane-2,3-diol

(2R)-1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

1-naphthyl N-acetyl-beta-D-glucosaminide

1-naphthyl N-acetyl-beta-D-glucosaminide

C18H21NO6 (347.1369)


An N-acetyl-beta-D-glucosaminide in which the anomeric hydroxy hydrogen is replaced by a 1-naphthyl group.

   

3-Epimacronine

3-Epimacronine

C18H21NO6 (347.1369)


   

8-oxo-dAMP

8-oxo-dAMP

C10H14N5O7P (347.0631)


A purine 2-deoxyribonucleoside 5-diphosphate that is the 8-oxo derivative of dADP.

   

Adenosine 2-phosphate

Adenosine 2-phosphate

C10H14N5O7P (347.0631)


   

3-AMP

3-AMP

C10H14N5O7P (347.0631)


An adenosine 3-phosphate with a monophosphate group at the 3-position.

   

5-carboxymethylaminomethyl-2-thiouridine

5-carboxymethylaminomethyl-2-thiouridine

C12H17N3O7S (347.0787)


A thiouridine that is 2-thiouridine bearing an additional carboxymethylaminomethyl substituent at position 5 on the thiouracil ring.

   

2-hydroxy-7-methoxy-10,13-dimethyl-9,18-dioxo-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1(19),3(8),4,6,12,14,16-heptaen-10-ium-11-ide

2-hydroxy-7-methoxy-10,13-dimethyl-9,18-dioxo-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1(19),3(8),4,6,12,14,16-heptaen-10-ium-11-ide

C21H17NO4 (347.1158)


   

7-hydroxy-19-[(1s)-1-hydroxyethyl]-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

7-hydroxy-19-[(1s)-1-hydroxyethyl]-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C20H17N3O3 (347.127)


   

methyl (2s)-2-hydroxy-3,3-dimethoxy-4-methyl-1,9-dioxocyclopenta[b]quinoline-2-carboxylate

methyl (2s)-2-hydroxy-3,3-dimethoxy-4-methyl-1,9-dioxocyclopenta[b]quinoline-2-carboxylate

C17H17NO7 (347.1005)


   

(1s,13s,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol

(1s,13s,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol

C18H21NO6 (347.1369)


   

(2r)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-methylbutane-2,3-diol

(2r)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

methyl 2-hydroxy-3-{4-[5-hydroxy-4-(2-methylpropyl)-2-oxopyrrol-3-yl]phenoxy}propanoate

methyl 2-hydroxy-3-{4-[5-hydroxy-4-(2-methylpropyl)-2-oxopyrrol-3-yl]phenoxy}propanoate

C18H21NO6 (347.1369)


   

9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2(10),3,8-trien-11-ol

9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2(10),3,8-trien-11-ol

C18H21NO6 (347.1369)


   

(2s)-1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

(2s)-1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(1s)-21-methyl-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-12-carboxylic acid

(1s)-21-methyl-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-12-carboxylic acid

C20H17N3O3 (347.127)


   

9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol

9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol

C18H21NO6 (347.1369)


   

15-hydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

15-hydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

C18H21NO6 (347.1369)


   

(1r,5's,6'r,7'ar)-5',6'-dihydroxy-5,6-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one

(1r,5's,6'r,7'ar)-5',6'-dihydroxy-5,6-dimethoxy-1'-methyl-3',5',6',7'a-tetrahydro-2'h-spiro[2-benzofuran-1,7'-indol]-3-one

C18H21NO6 (347.1369)


   

(2s,3s,6r,12r)-3,12-dihydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-10-ium-10-olate

(2s,3s,6r,12r)-3,12-dihydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-10-ium-10-olate

C18H21NO6 (347.1369)


   

1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

1-({7,8-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione

4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione

C18H21NO6 (347.1369)


   

11-β-hydroxycephalotaxine β-n-oxide

NA

C18H21NO6 (347.1369)


{"Ingredient_id": "HBIN000367","Ingredient_name": "11-\u03b2-hydroxycephalotaxine \u03b2-n-oxide","Alias": "NA","Ingredient_formula": "C18H21NO6","Ingredient_Smile": "COC1=CC23CCC[N+]2(CC(C4=CC5=C(C=C4C3C1O)OCO5)O)[O-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9901","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-carboxyevodiamine

NA

C20H17N3O3 (347.127)


{"Ingredient_id": "HBIN013133","Ingredient_name": "7-carboxyevodiamine","Alias": "NA","Ingredient_formula": "C20H17N3O3","Ingredient_Smile": "NA","Ingredient_weight": "347.37","OB_score": "NA","CAS_id": "69754-32-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7462;19315","PubChem_id": "NA","DrugBank_id": "NA"}

   

Aporphin

NA

C19H22ClNO3 (347.1288)


{"Ingredient_id": "HBIN016514","Ingredient_name": "Aporphin","Alias": "NA","Ingredient_formula": "C19H22ClNO3","Ingredient_Smile": "C[NH+]1CCC2=CC(=C(C3=C2C1CC4=C3C(=CC=C4)OC)O)OC.[Cl-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32984","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4,6-dihydroxy-12-methoxy-7-methyl-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

4,6-dihydroxy-12-methoxy-7-methyl-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C17H21N3O5 (347.1481)


   

9-hydroxy-7,9-dimethoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

9-hydroxy-7,9-dimethoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

C21H17NO4 (347.1158)


   

11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one

11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one

C20H17N3O3 (347.127)


   

(1s,13r,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol

(1s,13r,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-ol

C18H21NO6 (347.1369)


   

(2r)-1-({4,6-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

(2r)-1-({4,6-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(3as)-6,8-dihydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

(3as)-6,8-dihydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

C20H13NO5 (347.0794)


   
   

(2s)-1-({6,7-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

(2s)-1-({6,7-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(3s,4s)-4-(5,7-dihydroxy-2-methyl-4-oxochromen-8-yl)-1-methylpiperidin-3-yl acetate

(3s,4s)-4-(5,7-dihydroxy-2-methyl-4-oxochromen-8-yl)-1-methylpiperidin-3-yl acetate

C18H21NO6 (347.1369)


   

(3s,4'r)-2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

(3s,4'r)-2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

C19H13N3O4 (347.0906)


   

(1s,4z,6s,7r)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione

(1s,4z,6s,7r)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione

C18H21NO6 (347.1369)


   

(7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O4S (347.094)


   

(1s,2s,6r,8s,9r,10s)-15-hydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

(1s,2s,6r,8s,9r,10s)-15-hydroxy-9,16-dimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

C18H21NO6 (347.1369)


   

(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O4S (347.094)


   

1-({6,7-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

1-({6,7-dimethoxyfuro[2,3-b]quinolin-4-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(4r,7r)-4,6-dihydroxy-12-methoxy-7-methyl-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4r,7r)-4,6-dihydroxy-12-methoxy-7-methyl-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C17H21N3O5 (347.1481)


   

6,8-dihydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

6,8-dihydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

C20H13NO5 (347.0794)


   

(2s)-2-[(1r)-6-bromo-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-1-methylpyrrolidine

(2s)-2-[(1r)-6-bromo-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]-1-methylpyrrolidine

C17H22BrN3 (347.0997)


   

17,18-dimethoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

17,18-dimethoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C20H17N3O3 (347.127)


   

(2s)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

(2s)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(3r,6r)-6-(1h-indol-3-ylmethyl)-3-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

(3r,6r)-6-(1h-indol-3-ylmethyl)-3-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

C17H21N3O3S (347.1304)


   

(2s,3s,6r,10r,12r)-3,12-dihydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-10-ium-10-olate

(2s,3s,6r,10r,12r)-3,12-dihydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-10-ium-10-olate

C18H21NO6 (347.1369)


   

(2r)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

(2r)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(1r,13s,16s,17r)-13,17-dihydroxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-16-yl acetate

(1r,13s,16s,17r)-13,17-dihydroxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-16-yl acetate

C18H21NO6 (347.1369)


   

7-[(4-chloro-3-methylbut-2-en-1-yl)oxy]-4,8-dimethoxyfuro[2,3-b]quinoline

7-[(4-chloro-3-methylbut-2-en-1-yl)oxy]-4,8-dimethoxyfuro[2,3-b]quinoline

C18H18ClNO4 (347.0924)


   

(3r,6r)-3-(1h-indol-3-ylmethyl)-6-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

(3r,6r)-3-(1h-indol-3-ylmethyl)-6-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

C17H21N3O3S (347.1304)


   

(7s,8s)-11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one

(7s,8s)-11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,10,12-tetraen-2-one

C20H17N3O3 (347.127)


   

18-methoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione

18-methoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione

C20H17N3O3 (347.127)


   

3-(1h-indol-3-ylmethyl)-6-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

3-(1h-indol-3-ylmethyl)-6-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

C17H21N3O3S (347.1304)


   

[3-hydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

[3-hydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

C10H14N5O7P (347.0631)


   

(4r,5r,7e,9s,11r)-3,5,14-trihydroxy-4-methyl-17-oxa-2-azatricyclo[7.6.2.0¹²,¹⁶]heptadeca-1(15),2,7,12(16),13-pentaen-11-yl acetate

(4r,5r,7e,9s,11r)-3,5,14-trihydroxy-4-methyl-17-oxa-2-azatricyclo[7.6.2.0¹²,¹⁶]heptadeca-1(15),2,7,12(16),13-pentaen-11-yl acetate

C18H21NO6 (347.1369)


   

(2r,3r,4s,5r)-2-{6-[(furan-2-ylmethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-{6-[(furan-2-ylmethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C15H17N5O5 (347.123)


   

19-methoxy-3,5-dioxa-11-azahexacyclo[9.9.2.0²,⁶.0⁸,²¹.0¹⁴,²².0¹⁵,²⁰]docosa-1(21),2(6),7,14(22),15(20),16,18-heptaene-12,13-dione

19-methoxy-3,5-dioxa-11-azahexacyclo[9.9.2.0²,⁶.0⁸,²¹.0¹⁴,²².0¹⁵,²⁰]docosa-1(21),2(6),7,14(22),15(20),16,18-heptaene-12,13-dione

C20H13NO5 (347.0794)


   

23-methoxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2(10),3,8,11,14(22),15,17(21),23-nonaene

23-methoxy-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2(10),3,8,11,14(22),15,17(21),23-nonaene

C20H13NO5 (347.0794)


   

methyl 4-{6-methoxy-9-methyl-8-oxo-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-2-methylbutanoate

methyl 4-{6-methoxy-9-methyl-8-oxo-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-2-methylbutanoate

C18H21NO6 (347.1369)


   

11-methoxy-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2(10),3,8,11,14(22),15,20,23-nonaene

11-methoxy-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2(10),3,8,11,14(22),15,20,23-nonaene

C20H13NO5 (347.0794)


   

methyl 2-hydroxy-3,3-dimethoxy-4-methyl-1,9-dioxocyclopenta[b]quinoline-2-carboxylate

methyl 2-hydroxy-3,3-dimethoxy-4-methyl-1,9-dioxocyclopenta[b]quinoline-2-carboxylate

C17H17NO7 (347.1005)


   

1-({4,6-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

1-({4,6-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)ethanimidic acid

n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)ethanimidic acid

C20H17N3O3 (347.127)


   

(11s,12r)-11-ethoxy-12-hydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

(11s,12r)-11-ethoxy-12-hydroxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C20H17N3O3 (347.127)


   

7-hydroxy-19-(1-hydroxyethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

7-hydroxy-19-(1-hydroxyethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C20H17N3O3 (347.127)


   

12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2(10),3,8,14(22),15,20,23-octaen-11-one

12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2(10),3,8,14(22),15,20,23-octaen-11-one

C20H13NO5 (347.0794)


   

6-(1h-indol-3-ylmethyl)-3-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

6-(1h-indol-3-ylmethyl)-3-isopropyl-6-(methylsulfanyl)pyrazine-2,3,5-triol

C17H21N3O3S (347.1304)


   

n-[(2r)-2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl]ethanimidic acid

n-[(2r)-2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl]ethanimidic acid

C20H17N3O3 (347.127)


   

(2s)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-methylbutane-2,3-diol

(2s)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-methylbutane-2,3-diol

C18H21NO6 (347.1369)


   

(1r,4z,6r,7r)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione

(1r,4z,6r,7r)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-diene-3,8,15-trione

C18H21NO6 (347.1369)


   

2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

2-hydroxy-4'-(4-oxoquinazolin-3-yl)spiro[indole-3,2'-oxolan]-5'-one

C19H13N3O4 (347.0906)


   

7-{[(2e)-4-chloro-3-methylbut-2-en-1-yl]oxy}-4,8-dimethoxyfuro[2,3-b]quinoline

7-{[(2e)-4-chloro-3-methylbut-2-en-1-yl]oxy}-4,8-dimethoxyfuro[2,3-b]quinoline

C18H18ClNO4 (347.0924)


   

methyl (2r)-4-{6-methoxy-9-methyl-8-oxo-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-2-methylbutanoate

methyl (2r)-4-{6-methoxy-9-methyl-8-oxo-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-2-methylbutanoate

C18H21NO6 (347.1369)


   

(1s,11r,13r,15r,16s,18r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2(10),3,8-trien-11-ol

(1s,11r,13r,15r,16s,18r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2(10),3,8-trien-11-ol

C18H21NO6 (347.1369)